ArticleHeliyon2024

Exploring a novel long-acting glucagon-like peptide-1 receptor agonist built on the albumin-binding domain and XTEN scaffolds.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.